The anti-inflammasome activity of pterostilbene in hyperuricemia model has been demonstrated by an in vitro assay where NLRP3 inflammasome and epithelial–mesenchymal transition in renal cells have been stimulated by TGF-β [80]. The gene discussed is NLRP3; the disease is hyperuricemia.